BG103704A - New compounds - Google Patents

New compounds

Info

Publication number
BG103704A
BG103704A BG103704A BG10370499A BG103704A BG 103704 A BG103704 A BG 103704A BG 103704 A BG103704 A BG 103704A BG 10370499 A BG10370499 A BG 10370499A BG 103704 A BG103704 A BG 103704A
Authority
BG
Bulgaria
Prior art keywords
new compounds
clavams
microorganisms
improving
processes
Prior art date
Application number
BG103704A
Other languages
Bulgarian (bg)
English (en)
Inventor
Barry Barton
John Griffin
Cecilia Anders
Susan Jensen
Roy MOSHER
Ashish Paradkar
Original Assignee
Smithkline Beecham P.L.C.
The Governors Of The University Of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C., The Governors Of The University Of Alberta filed Critical Smithkline Beecham P.L.C.
Publication of BG103704A publication Critical patent/BG103704A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG103704A 1997-02-04 1999-09-01 New compounds BG103704A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product
PCT/EP1998/000644 WO1998033896A2 (fr) 1997-02-04 1998-02-02 Nouvelles compositions

Publications (1)

Publication Number Publication Date
BG103704A true BG103704A (en) 2000-05-31

Family

ID=10807030

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103704A BG103704A (en) 1997-02-04 1999-09-01 New compounds

Country Status (32)

Country Link
US (5) US6936458B1 (fr)
EP (2) EP0970198B1 (fr)
JP (2) JP4227199B2 (fr)
KR (2) KR100514964B1 (fr)
CN (2) CN1192107C (fr)
AP (1) AP1320A (fr)
AR (2) AR011100A1 (fr)
AT (1) ATE312926T1 (fr)
AU (1) AU735782B2 (fr)
BG (1) BG103704A (fr)
BR (1) BR9807144A (fr)
CA (1) CA2279207A1 (fr)
DE (1) DE69832783T2 (fr)
DZ (1) DZ2413A1 (fr)
EA (1) EA003773B1 (fr)
ES (1) ES2255149T3 (fr)
GB (1) GB9702218D0 (fr)
HU (1) HUP0001048A3 (fr)
ID (1) ID22144A (fr)
IL (1) IL131043A0 (fr)
MA (1) MA24464A1 (fr)
MY (1) MY140928A (fr)
NO (1) NO993758D0 (fr)
NZ (1) NZ336894A (fr)
OA (1) OA11082A (fr)
PL (1) PL334961A1 (fr)
SK (1) SK105499A3 (fr)
TR (1) TR199901862T2 (fr)
TW (2) TW589377B (fr)
UY (2) UY24874A1 (fr)
WO (1) WO1998033896A2 (fr)
ZA (1) ZA98868B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7983400A (en) * 1999-09-16 2001-04-17 Johns Hopkins University, The Improvement of clavulanic acid production
JP2003512832A (ja) * 1999-10-22 2003-04-08 スミスクライン ビーチャム パブリック リミテッド カンパニー Ｌａｔおよびｃｖｍ遺伝子の欠失した５ｒクラバム産生微生物
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (fr) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Procédé de production d'acide clavulanique
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
CN114072493A (zh) 2019-07-05 2022-02-18 葛兰素史密斯克莱知识产权（第2 号）有限公司 棒状链霉菌

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
SE421796B (sv) * 1975-02-07 1982-02-01 Glaxo Lab Ltd Forfarande for rening av klavulansyra och dess salter
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (fr) * 1993-10-08 2006-12-05 Susan E. Jensen Sequence d'adn codant pour des enzymes de la synthese de l'acide clavulanique

Also Published As

Publication number Publication date
US20030124690A1 (en) 2003-07-03
NZ336894A (en) 2001-08-31
AR011100A1 (es) 2000-08-02
US20070298470A1 (en) 2007-12-27
TR199901862T2 (xx) 2000-12-21
EP1405913A2 (fr) 2004-04-07
DZ2413A1 (fr) 2003-01-04
TW200307041A (en) 2003-12-01
EA199900718A1 (ru) 2000-02-28
EP0970198A2 (fr) 2000-01-12
DE69832783T2 (de) 2006-07-20
JP5042186B2 (ja) 2012-10-03
KR20050053794A (ko) 2005-06-08
AU6295398A (en) 1998-08-25
CN1696301A (zh) 2005-11-16
MA24464A1 (fr) 1998-10-01
UY25197A1 (es) 1998-11-27
KR20000070723A (ko) 2000-11-25
AU735782B2 (en) 2001-07-12
JP2009022298A (ja) 2009-02-05
ES2255149T3 (es) 2006-06-16
GB9702218D0 (en) 1997-03-26
EP1405913A3 (fr) 2004-08-04
ZA98868B (en) 1999-08-03
WO1998033896A3 (fr) 1998-11-19
EA003773B1 (ru) 2003-08-28
IL131043A0 (en) 2001-01-28
EP0970198B1 (fr) 2005-12-14
CN1251612A (zh) 2000-04-26
MY140928A (en) 2010-02-12
US20030166175A1 (en) 2003-09-04
HUP0001048A2 (hu) 2000-08-28
CA2279207A1 (fr) 1998-08-06
HUP0001048A3 (en) 2001-09-28
US6936458B1 (en) 2005-08-30
PL334961A1 (en) 2000-03-27
AR018304A2 (es) 2001-11-14
ID22144A (id) 1999-09-09
BR9807144A (pt) 2000-01-25
US20030022321A1 (en) 2003-01-30
DE69832783D1 (de) 2006-01-19
SK105499A3 (en) 2000-05-16
ATE312926T1 (de) 2005-12-15
CN1192107C (zh) 2005-03-09
NO993758L (no) 1999-08-03
NO993758D0 (no) 1999-08-03
OA11082A (en) 2003-03-13
AP1320A (en) 2004-10-29
JP4227199B2 (ja) 2009-02-18
UY24874A1 (es) 2001-07-31
WO1998033896A2 (fr) 1998-08-06
US7344869B2 (en) 2008-03-18
KR100514964B1 (ko) 2005-09-15
AP9901614A0 (en) 1999-09-30
TW589377B (en) 2004-06-01
JP2001511001A (ja) 2001-08-07

Similar Documents

Publication Publication Date Title
CA2145630A1 (fr) Microorganismes produisant du tryptophane et procede de fabrication
AU2294788A (en) Apparatus for the intensive, controlled production of microorganisms by photosynthesis
AU5485698A (en) Oxyiminopregnancarbolactone
CA2264066A1 (fr) Composes antiparasitaires isoles de la fermentation du nodulisporium sp
AU4631596A (en) Process for the microbiological production of pha-polymers
MX9700257A (es) Nuevas estreptograminas y procedimiento de preparacion de estreptograminas por mutasintesis.
MY117381A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
AU2777097A (en) Process and carrier for the production of isomaltulose by immobilized micro-organisms
BG103704A (en) New compounds
YU13499A (sh) Primena 1-hidroksi-2-piridona za lečenje seboroitičnog dermatitisa
AU3109300A (en) Production of ascorbic acid using yeast
WO1997038124A3 (fr) Procede enzymatique pour la preparation stereoselective d'amides therapeutiques
GR3033402T3 (en) Selective process for the deacylation of acylated compounds
AU8631698A (en) A process for the preparation of tetraazamacrocycles
WO2001042250A3 (fr) Procede de production de diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane et sym-tetraalkyltetraphenyl-cyclotetrasiloxane
AU9254298A (en) Novel cyclomaltodextrin glucanotransferase variants
EP0911415A3 (fr) Production microbiologique d'acide L-ascorbique
AU3814800A (en) Enantiomers of mercapto lactones and processes for their synthesis
AU3774097A (en) Intermediates for the preparation of 2-imidazoline-5-ones
PL293902A1 (en) Method of obatining novel 4-substituted azetidinones as precursors of 2-substituted 2-carboxycarbaprenemic antibiotics
BG102599A (en) Macrocyclic compounds produced from suboxide units
BG108151A (en) Caloporoside derivatives, methods for the production thereof and their use
GB9424950D0 (en) Novel process
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
CA2189682A1 (fr) Procede de production de trans-4-hydroxy-l-proline